In view of our finding that expression of E-cadherin is decreased in LCN2-overexpressing cells, compared with controls, and conversely rescued in LCN2-depleted cells, we propose that LCN2 accelerates tumor cell migration through alterations in E-cadherin expression. The gene discussed is LCN2; the disease is neoplasm.